Showing results (271-280 of 301) with videos related to
Sort By:
Pageof 31
Biochemical Pharmacology|February 27, 2017
GIP(3-30)NH2 is a potent competitive antagonist of the GIP receptor and effectively inhibits GIP-mediated insulin, glucagon, and somatostatin releaseA H Sparre-Ulrich, M N Gabe, L S Gasbjerg, et al.Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|December 22, 1998
High levels of serum allopregnanolone in women with premature ovarian failureF Bernardi, B Hartmann, E Casarosa, et al.Regulatory Peptides|March 21, 2013
Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled studyK B Madsen, C Askov-Hansen, R M Naimi, et al.Regulatory Peptides|March 19, 2013
A dose-equivalent comparison of the effects of continuous subcutaneous glucagon-like peptide 2 (GLP-2) infusions versus meal related GLP-2 injections in the treatment of short bowel syndrome (SBS) patientsR M Naimi, K B Madsen, C Askov-Hansen, et al.Journal of Toxicology and Environmental Health. Part B, Critical Reviews|September 24, 2015
Techniques and Protocols for Dispersing Nanoparticle Powders in Aqueous Media-Is there a Rationale for Harmonization?Nanna B Hartmann, Keld Alstrup Jensen, Anders Baun, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|November 30, 2000
GLP-2 stimulates intestinal growth in premature TPN-fed pigs by suppressing proteolysis and apoptosisD G Burrin, B Stoll, R Jiang, et al.Journal of Animal Science|March 26, 2014
Glucagon-like peptide 2 treatment may improve intestinal adaptation during weaningT Thymann, I Le Huërou-Luron, Y M Petersen, et al.Frontiers in Microbiology|January 20, 2017
Improved Culture Medium (TiKa) for Mycobacterium avium Subspecies Paratuberculosis (MAP) Matches qPCR Sensitivity and Reveals Significant Proportions of Non-viable MAP in Lymphoid Tissue of Vaccinated MAP Challenged AnimalsTim J Bull, Tulika Munshi, Heidi Mikkelsen, et al.Virology|September 25, 1999
Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infectionM C Jung, B Hartmann, J T Gerlach, et al.Diabetes, Obesity & Metabolism|July 22, 2014
Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): implications for GLP-1 measurements in clinical studiesM J Bak, N J Wewer Albrechtsen, J Pedersen, et al.Pageof 31